The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Authors
Keywords
-
Journal
MEDICAL ONCOLOGY
Volume 38, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-18
DOI
10.1007/s12032-021-01516-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of BAFF and APRIL in rheumatoid arthritis
- (2019) Arezoo G. Shabgah et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL
- (2018) I Parodis et al. LUPUS
- The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting
- (2018) Laurie Baert et al. JOURNAL OF AUTOIMMUNITY
- BAFF and BAFF-Receptor in B Cell Selection and Survival
- (2018) Cristian R. Smulski et al. Frontiers in Immunology
- Regulation of Inflammation- and Infection-Driven Hematopoiesis
- (2017) Steffen Boettcher et al. TRENDS IN IMMUNOLOGY
- Deferiprone-induced agranulocytosis: 20 years of clinical observations
- (2016) Fernando Tricta et al. AMERICAN JOURNAL OF HEMATOLOGY
- BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis
- (2016) Roham Parsa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The BAFFling effects of rituximab in lupus: danger ahead?
- (2016) Michael R. Ehrenstein et al. Nature Reviews Rheumatology
- How we diagnose and treat neutropenia in adults
- (2016) Jan Palmblad et al. Expert Review of Hematology
- Granulocyte colony-stimulating factor reprograms bone marrow stromal cells to actively suppress B lymphopoiesis in mice
- (2015) R. B. Day et al. BLOOD
- Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis
- (2012) Baptiste N. Jaeger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections
- (2011) Daniel Tesfa et al. ARTHRITIS AND RHEUMATISM
- Neutropenia after rituximab treatment
- (2011) Ofir Wolach et al. CURRENT OPINION IN HEMATOLOGY
- Clinical presentation and management of drug-induced agranulocytosis
- (2011) Emmanuel Andrès et al. Expert Review of Hematology
- Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms
- (2011) Daniel Tesfa et al. Expert Review of Hematology
- Rituximab-induced late onset neutropenia in newly-diagnosed B-cell lymphoma correlates with Fc receptor FcγRIIIa 158(V/F) polymorphism
- (2010) Szu-Chin Li et al. AMERICAN JOURNAL OF HEMATOLOGY
- Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia
- (2008) K Stamatopoulos et al. LEUKEMIA
- Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis
- (2008) Daniel Tesfa et al. MEDICAL ONCOLOGY
- Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
- (2007) Patrizia Scapini et al. IMMUNOLOGY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started